Redx Pharma

Redx Pharma (AIM:REDX) has established itself as one of the largest biotechnology companies in Europe. The company is focused on the development of a wide range of early stage, proprietary, small molecule therapeutics to address high unmet medical needs in cancer and infectious disease. The Company has recently secured commercial deals for some of its programs. Acceleris has provided £13m of EIS funding to Redx prior to the IPO and the Company has been successful in securing approximately £15m of grant support to allow it to grow to over 180 staff over two sites in Liverpool and Alderley Park.


Acceleris Capital, 28-29 Bridgeman Terrace, Wigan, Greater Manchester, WN1 1TD

Tel: 01942 35 66 55

General Enquiry Investment Enquiry Upload Business Plan